Introducing a new monthly feature focused on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.
| Target | Investors | Amount | Date |
|---|---|---|---|
| Bicycle Therapeutics | Vertex Ventures HC, with new investors Cambridge Innovation Capital and Longwood Fund and existing investors Novartis Venture Fund, SROne, SVLS and Atlas Venture, with new investors Cambridge Innovation Capital and Longwood Fund and existing investors Novartis Venture Fund, SROne, SVLS and Atlas Ventures | $51.4 million, Series B | June 1, 2017 |
| Bright Health | Greenspring Associates, joined by Greycroft Partners, Redpoint Ventures and Cross Creek Advisors. Existing lead investor New Enterprise Associates, Bessemer Venture Partners and Flare Capital Partners also participated. | $160 million, Series B | June 1, 2017 |
| Monteris Medical | SightLine Partners and Versant Ventures | $26.6 million, Series C | June 2, 2017 |
| Eloxx Pharmaceutical | Pontifax Venture Capital with Quark Ventre and GF Securities Co. Ltd. | $24 million, Series C | June 9, 2017 |
| MyHealthTeams | Qiming U.S. Healthcare Fund, joined by Adams Street Partners, CVS Health, The Westly Group, HealthTech Capital and 500 Startups. | $7.3 million, Series C | June 12, 2017 |
| Art Medical | Advanced Medical Technologies, LLC | $20 million | June 14, 2017 |
| AEye Inc. | Kleiner Perkins Caulfield Byers, Airbus Ventures, Intel Capital, Tyche Partners and others | $16 million, Series A | June 14, 2017 |
| Orum Therapeutics | InterVest Co., Ltd., KB Investment/Solidus Investment and LB Investment | $8 million, Series A | June 14, 2017 |
| Omada Health | Cigna, U.S. Venture Partners, Andreessen Horowitz, Norwest Venture Partners, Humana, Kaiser Permanente Ventures, Providence Ventures, dRx Capital and GE Ventures | $50 million | June 14, 2017 |
| Checkmate Pharamceuticals | F-Prime Capital Partners | $27 million, Series B | June 15, 2017 |
| Regroup Therapy | OSF Ventures, Hyde Park Angels, OCA Ventures, HLM Venture Partners, Furthur Fund and Impact Engine | $6 million, Series A | June 15, 2017 |
| Osso VR | SignalFire | $2 million, Series Seed | June 15, 2017 |
| TwelveStone Health Partners | Claritas Capital | $3.35 million | June 20, 2017 |
| CirrusMD | Colorado Impact Fund, Bootstrap Incubation, Three Leaf Ventures, Rockies Venture Fund, Service Provider Capital, Sand Hill Angels and New York Angels | $7 million, Series A | June 20, 2017 |
| Avitide, Inc. | Sands Capital Ventures, LLC, Mithril Capital Management, Polaris Partners, NeoMed Management, OrbiMed Advisors and Borealis Ventures | Not disclosed, Series E | June 21, 2017 |
| Syntimmune, Inc. | Apple Tree Partners and others | $50 million, Series B | June 21, 2017 |
| Provention Bio, Inc. | MDB Capital Group, JJDC, Inc. and JDRF Fund, LLC | $28.4 million, Series A | June 26, 2017 |
| Otto Bock HealthCare GmbH | EQT | 20% equity stake | June 26, 2017 |
| ORIG3N | Hatteras Venture Partners, Spectrum Health Venture, LabCorp, Syno Capital, KRB-KORUS Fund, MGC Venture Partners, DEFTA Partners and 180 Degree Capital | $20 million | June 27, 2017 |
| DayTwo | Johnson & Johnson Innovation - JJDC, Inc. and Seventure Partners | $12 million, Series A | June 27, 2017 |
| Your.MD | Orkla Ventures, Smedvig Capital AS and other existing shareholders | $10 million | June 27, 2017 |
| Glooko | Georgian Partners, with Canaan Partners, Medtronic and Social Capital | $35 million, Series C | June 28, 2017 |
| PatientPoint | Searchlight Capital Partners and Silver Point Capital | $140 million | June 28, 2017 |
| KRY | Accel, Index Ventures, Creandum and Project A | $22.67 million | June 28, 2017 |
